GMMRX
Price
$10.26
Change
+$0.02 (+0.20%)
Updated
Dec 3 closing price
Net Assets
220.51M
JFLJX
Price
$13.38
Change
+$0.03 (+0.22%)
Updated
Dec 3 closing price
Net Assets
4.27B
Interact to see
Advertisement

GMMRX vs JFLJX

Header iconGMMRX vs JFLJX Comparison
Open Charts GMMRX vs JFLJXBanner chart's image
Nationwide Inv Dest Mod Cnsrv R
Price$10.26
Change+$0.02 (+0.20%)
VolumeN/A
Net Assets220.51M
JPMorgan Investor Conservative Growth R6
Price$13.38
Change+$0.03 (+0.22%)
VolumeN/A
Net Assets4.27B
GMMRX vs JFLJX Comparison Chart in %
View a ticker or compare two or three
VS
GMMRX vs. JFLJX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMMRX is a Hold and JFLJX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFLJX has more cash in the bank: 4.27B vs. GMMRX (221M). JFLJX pays higher dividends than GMMRX: JFLJX (3.65) vs GMMRX (2.70). GMMRX was incepted earlier than JFLJX: GMMRX (22 years) vs JFLJX (8 years). GMMRX (1.16) is less costly to investors than JFLJX (0.44). GMMRX is a more actively managed with annual turnover of: 35.30 vs. JFLJX (11.00). GMMRX has a lower initial minimum investment than JFLJX: GMMRX (0) vs JFLJX (15000000). JFLJX annual gain was more profitable for investors over the last year : 6.52 vs. GMMRX (1.09). JFLJX return over 5 years is better than : 13.73 vs. GMMRX (10.04).
GMMRXJFLJXGMMRX / JFLJX
Total Expense Ratio1.160.44264%
Annual Report Gross Expense Ratio1.160.44264%
Fund Existence22 years8 years-
Gain YTD10.10510.45297%
Front LoadN/AN/A-
Min. Initial Investment015000000-
Min. Initial Investment IRAN/AN/A-
Net Assets221M4.27B5%
Annual Yield % from dividends2.703.6574%
Returns for 1 year1.096.5217%
Returns for 3 years15.3921.1773%
Returns for 5 years10.0413.7373%
Returns for 10 years22.32N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LYFIX16.300.43
+2.71%
AlphaCentric Life Sciences & Hlthcare I
IVKAX20.670.19
+0.93%
VY® Invesco Comstock A
JVACX40.020.35
+0.88%
JPMorgan Value Advantage C
TRGPX22.500.08
+0.36%
Nuveen Quant Mid Cap Growth Premier
BIERX28.290.08
+0.28%
Brandes International Equity R6